- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 4 - Pushing Reform through Immunotherapy
As the panelists explore the costs and value of genomic precision therapy and immunotherapy, Michael Kolodziej, MD, explains that multiple factors should be considered when determining the cost of care for a cancer patient. For instance, he believes that 30% of total healthcare costs for cancer patients is wastefully spent.
While curative immunotherapy is still not quite on the table, clinicians have already witnessed a “plateau of survival” for melanoma patients treated with ipilimumab, as explained by Jeffrey Weber, MD, PhD.
Dr Weber agrees that wasteful spending is a concern, and as he explains that survival is the ultimate goal for cancer treatment, he and Dr Kolodziej conclude that reimbursement models need to be addressed to eliminate wasteful spending, identify value, and provide meaningful outcomes.
Impact of Hospital-Physician Integration on Medicare Patient Mix
April 11th 2025This study found no evidence that hospital employment of physicians resulted in physicians treating sicker patients, undercutting claims that hospital-employed physicians serve a higher-acuity patient mix.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
